Catalyst Event
Tempus AI Inc (TEM) · Earnings Release
From KEDI U.S. Medical AI Index (KUSMAI)
5/5/2026, 12:00:00 AM
As quarterly earnings are key volatility events for growth-stage AI companies, Tempus AI's Q1 2026 earnings release on May 5, 2026, is scheduled
Korean Translation
분기 실적 발표는 성장 단계 AI 기업의 주요 변동성 요인이므로, 템퍼스 AI의 2026년 5월 5일 2026년 1분기 실적 발표 예정됨
Related Recent Events
Recursion Pharmaceauticals Inc (RXRX) · Earnings Release
First quarter 2026 earnings release is scheduled for May 11, 2026, with analysts forecasting an EPS of approximately -$0.25. This event is critical for monitoring cash burn, justifying a medium importance estimate (expected 5-10% impact), forecasted
5/11/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Earnings Release
Q1 2026 earnings release is scheduled; medium importance is estimated based on expected >=5% price impact.
4/30/2026, 12:00:00 AM
Alphabet Inc (GOOGL) · Earnings Release
Alphabet's Q1 2026 earnings release on April 23, 2026, with low importance estimated as no market reaction has occurred yet, expected.
4/23/2026, 12:00:00 AM
Intuitive Surgical Inc (ISRG) · Earnings Release
Q1 2026 earnings release and conference call for 2026-04-21 scheduled. Low importance is estimated due to the routine nature of the announcement scheduled.
4/21/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Other
FDA decision on oral weight-loss drug orforglipron is expected; high importance is estimated due to potential for >=10% price impact.
4/10/2026, 12:00:00 AM
Recursion Pharmaceauticals Inc (RXRX) · Other
Vicki Goodman, M.D., with over 20 years of oncology drug development experience, is scheduled to become the new Chief Medical Officer, effective April 6, 2026. This appointment is a key milestone for clinical development, justifying a medium importance estimate (expected 5-10% impact), scheduled
4/6/2026, 12:00:00 AM